Inter-rater agreement of HER2-low scores between expert breast pathologists and the Visiopharm digital image analysis application (HER2 APP, CE2797).
Saved in:
| Title: | Inter-rater agreement of HER2-low scores between expert breast pathologists and the Visiopharm digital image analysis application (HER2 APP, CE2797). |
|---|---|
| Authors: | Parry S; UK National External Quality Assessment Scheme for Immunocytochemistry and In-Situ Hybridisation, London, UK., Zabaglo L; UK National External Quality Assessment Scheme for Immunocytochemistry and In-Situ Hybridisation, London, UK., Shaaban AM; Department of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.; Cellular Pathology, Queen Elizabeth Hospital Birmingham, Birmingham, UK., Dodson A; UK National External Quality Assessment Scheme for Immunocytochemistry and In-Situ Hybridisation, London, UK. |
| Source: | The journal of pathology. Clinical research [J Pathol Clin Res] 2025 Nov; Vol. 11 (6), pp. e70051. |
| Publication Type: | Journal Article; Comparative Study |
| Journal Info: | Publisher: Wiley Blackwell Country of Publication: England NLM ID: 101658534 Publication Model: Print Cited Medium: Internet ISSN: 2056-4538 (Electronic) Linking ISSN: 20564538 NLM ISO Abbreviation: J Pathol Clin Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
